Sarcopenia in daily practice: assessment and management

Charlotte Beaudart(University of Liège), Eugène McCloskey(University of Sheffield), Olivier Bruyère(University of Liège), Matteo Cesari(Université Toulouse III - Paul Sabatier), Yves Rolland(Université Toulouse III - Paul Sabatier), René Rizzoli(University Hospital of Geneva), Islène Araujo de Carvalho(World Health Organization), Jotheeswaran Amuthavalli Thiyagarajan(World Health Organization), Ivan Bautmans(Vrije Universiteit Brussel), Marie-Claude Bertière(Centre de Recherche en Nutrition Humaine d'Auvergne), Maria Luisa Brandi(University of Florence), Nasser M. Al‐Daghri(King Saud University), Nansa Burlet(University of Liège), Étienne Cavalier(University of Liège), Francesca Cerreta(Antibiotic Research UK), Antonio Cherubini(Istituti di Ricovero e Cura a Carattere Scientifico), Roger A. Fielding(Tufts University), Evelien Gielen(KU Leuven), Francesco Landi(Università Cattolica del Sacro Cuore), Jean Pétermans, Jean‐Yves Reginster(University of Liège), Marjolein Visser(Amsterdam UMC Location Vrije Universiteit Amsterdam), John А. Kanis(Australian Catholic University), Cyrus Cooper(University of Oxford)
BMC Geriatrics
October 5, 2016
Cited by 834Open Access
Full Text

Abstract

BACKGROUND: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. METHODS: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. RESULTS: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. CONCLUSIONS: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future.


Related Papers

No related papers found

Powered by citation graph analysis